Literature DB >> 1610367

Concentrations and molecular forms of human brain natriuretic peptide in plasma.

H Tateyama1, J Hino, N Minamino, K Kangawa, T Minamino, K Sakai, T Ogihara, H Matsuo.   

Abstract

Using a highly sensitive radioimmunoassay (RIA) system for human brain natriuretic peptide (BNP), immunoreactive (ir-) human BNP was found to be present in plasma, in addition to heart and brain tissue. Plasma concentrations of ir-BNP were 0.17-0.74 fmol/ml (mean: 0.35 fmol/ml) in normal young men, being about 1/17 of the plasma concentration of human atrial natriuretic peptide (ANP). In patients with heart disease, plasma concentration of ir-BNP increased about 100-fold (5.00-177.37 fmol/ml), being nearly comparable to that of ir-ANP, even though ANP concentration also increased about 7-fold. Two molecular forms of ir-BNP in plasma were identified as BNP-32 and gamma-BNP (pro-BNP), which are also found in cardiac atrium. In normal human plasma, gamma-BNP is the predominant molecular form, while the main form in cardiac atrium is BNP-32. These results suggest that biosynthesis and secretion of BNP are augmented in heart disease and that human BNP has a unique processing and metabolic system distinct from that of ANP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610367     DOI: 10.1016/0006-291x(92)91691-i

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.

Authors:  Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

2.  Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective.

Authors:  Noel S Lee; Lori B Daniels
Journal:  Card Fail Rev       Date:  2016-05

3.  Comparison of renal function under deliberate hypotension during epidural plus light-enflurane anesthesia and during enflurane anesthesia.

Authors:  Naoto Nagata; Mayumi Takasaki; Gohtaro Yoshikawa; Tadashi Agune; Michiyo Takeshita; Naoto Minamino
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

Review 4.  Molecular forms of natriuretic peptides in heart failure and their implications.

Authors:  Ye Olivia Xu-Cai; Qingyu Wu
Journal:  Heart       Date:  2009-05-17       Impact factor: 5.994

5.  Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides.

Authors:  Genna L Andrews; Christopher M Shuford; John C Burnett; Adam M Hawkridge; David C Muddiman
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-02-24       Impact factor: 3.205

6.  Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.

Authors:  J Eduardo Rame; S William Tam; Dennis McNamara; Manuel Worcel; Michael L Sabolinski; Alan H Wu; Daniel L Dries
Journal:  Circ Heart Fail       Date:  2009-09-28       Impact factor: 8.790

7.  The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.

Authors:  Satoru Suzuki; Seigo Sugiyama
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.